Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.
Boerrigter G, Costello-Boerrigter LC, Harty GJ, Lapp H, Burnett JC Jr. Boerrigter G, et al. Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R897-901. doi: 10.1152/ajpregu.00569.2006. Epub 2006 Oct 26. Am J Physiol Regul Integr Comp Physiol. 2007. PMID: 17068158 Free article.
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS, Burnett JC Jr. Cataliotti A, et al. Among authors: boerrigter g. Circulation. 2004 Apr 6;109(13):1680-5. doi: 10.1161/01.CIR.0000124064.00494.21. Epub 2004 Mar 15. Circulation. 2004. PMID: 15023890
Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure.
Cataliotti A, Schirger JA, Martin FL, Chen HH, McKie PM, Boerrigter G, Costello-Boerrigter LC, Harty G, Heublein DM, Sandberg SM, James KD, Miller MA, Malkar NB, Polowy K, Burnett JC Jr. Cataliotti A, et al. Among authors: boerrigter g. Circulation. 2005 Aug 9;112(6):836-40. doi: 10.1161/CIRCULATIONAHA.105.538520. Epub 2005 Aug 1. Circulation. 2005. PMID: 16061734 Clinical Trial.
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, Orlandi C, Burnett JC Jr. Costello-Boerrigter LC, et al. Among authors: boerrigter g. Am J Physiol Renal Physiol. 2006 Feb;290(2):F273-8. doi: 10.1152/ajprenal.00195.2005. Epub 2005 Sep 27. Am J Physiol Renal Physiol. 2006. PMID: 16189291 Free PMC article. Clinical Trial.
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
Cataliotti A, Chen HH, Schirger JA, Martin FL, Boerrigter G, Costello-Boerrigter LC, James KD, Polowy K, Miller MA, Malkar NB, Bailey KR, Burnett JC Jr. Cataliotti A, et al. Among authors: boerrigter g. Circulation. 2008 Oct 21;118(17):1729-36. doi: 10.1161/CIRCULATIONAHA.107.759241. Epub 2008 Oct 6. Circulation. 2008. PMID: 18838565 Free PMC article.
80 results